In tumor cells, the interaction between FGFR2, the progesterone receptor and STAT5 in the nucleus after FGF2 and medroxyprogesterone acetate (MPA) treatment has been associated with increased gene transcription and cell proliferation [34]. This evidence concerns the gene PGR and neoplasm.